Abstract
Voltage-gated sodium (NaV) channels are essential for cardiac electrical activity. While NaV1.5 is the primary cardiac isoform, the functional contributions of non-NaV1.5 isoforms remain poorly defined. This study introduces a chemical-genetic mouse model (NaV1.5-GX) that allows for the selective and reversible inhibition of NaV1.5. Our findings reveal a heterogeneous, chamber-specific landscape of sodium channel isoforms. Specifically, the right ventricle (RV) exhibits higher sensitivity to NaV1.5 inhibition compared to the left ventricle (LV) and atria. We identify distinct non-canonical isoforms—NaV1.8 in the LV, NaV1.1/1.3 in the RV, and NaV1.2/1.6/1.7 in the atria—that contribute to a "conduction reserve." These results provide a molecular framework for understanding chamber-specific cardiac pathologies such as Brugada syndrome.
Introduction
The NaV1.5 sodium channel has long been considered the sole driver of the rapid depolarization phase in cardiomyocytes. However, clinical phenomena, such as the right-ventricular predominance of Brugada syndrome and the chamber-specific efficacy of certain anti-arrhythmic drugs, suggest that other sodium channel isoforms play significant roles. Identifying these isoforms has been challenging due to the dominance of NaV1.5. This study addresses this gap by developing a tool to "silence" NaV1.5 and map the heart's true isoform landscape.
Methods: The NaV1.5-GX Chemical-Genetic Model
The researchers utilized CRISPR-Cas9 to engineer the NaV1.5-GX mouse model. In this model, the native NaV1.5 channel is modified to be sensitive to GX-674, a selective acyl-sulfonamide inhibitor that does not affect wild-type cardiac channels. This approach enables the precise, reversible inhibition of NaV1.5 both in vivo and in isolated cells.
Experimental techniques included whole-heart optical mapping with voltage-sensitive dyes and patch-clamp electrophysiology. By combining NaV1.5 inhibition with isoform-specific toxins (e.g., $\mu$-conotoxin GIIIB for NaV1.1/1.2/1.4), the team quantified the contribution of various "neuronal" sodium channels across different cardiac regions.
Results: Chamber-Specific Isoform Distribution
The study quantified the contribution of NaV1.5 to the total sodium current as 93% in the LV, 81% in the RV, and 78% in the left atrium (LA). This indicates that non-canonical isoforms contribute significantly more to the electrical workload in the atria and RV than previously thought.
Key regional findings include:
- Right Ventricle (RV): Highly sensitive to NaV1.5 inhibition, with a backup system enriched in NaV1.1 and NaV1.3.
- Left Ventricle (LV): More resilient to NaV1.5 inhibition, relying primarily on NaV1.8.
- Atria: Possess the highest "conduction reserve" (up to 22%), utilizing a diverse mix of NaV1.2, 1.6, and 1.7.
Acute administration of GX-674 in NaV1.5-GX mice resulted in severe conduction defects, including atrioventricular block and ventricular tachycardia, which were fully reversible upon drug washout.
Discussion
These findings challenge the NaV1.5-centric view of cardiac excitability and highlight a complex, regionalized isoform landscape. The increased sensitivity of the RV to NaV1.5 inhibition offers a compelling molecular explanation for the RV-specific manifestations of Brugada syndrome. Furthermore, the identification of chamber-specific "backup" channels suggests new pharmacological strategies for treating arrhythmias with greater precision and fewer side effects. Future research will explore how these isoform profiles are remodeled during chronic cardiac disease.
Summary updated